148 related articles for article (PubMed ID: 21891979)
21. Clinical features and in vitro susceptibilities of two varieties of Cryptococcus neoformans in Taiwan.
Chen YC; Chang SC; Shih CC; Hung CC; Luhbd KT; Pan YS; Hsieh WC
Diagn Microbiol Infect Dis; 2000 Mar; 36(3):175-83. PubMed ID: 10729660
[TBL] [Abstract][Full Text] [Related]
22. Epidemiological, Clinical and Outcome Aspects of Patients with Cryptococcosis Caused by Cryptococcus gattii from a Non-endemic Area of Brazil.
Damasceno-Escoura AH; de Souza ML; de Oliveira Nunes F; Pardi TC; Gazotto FC; Florentino DH; Mora DJ; Silva-Vergara ML
Mycopathologia; 2019 Feb; 184(1):65-71. PubMed ID: 30415450
[TBL] [Abstract][Full Text] [Related]
23. Recovery of Cryptococcus neoformans from the nasopharynx of AIDS patients.
Sukroongreung S; Eampokalap B; Tansuphaswadikul S; Nilakul C; Tantimavanich S
Mycopathologia; 1998-1999; 143(3):131-4. PubMed ID: 10353208
[TBL] [Abstract][Full Text] [Related]
24. Systemic fungal infections in patients with human inmunodeficiency virus.
Rodríguez-Cerdeira C; Arenas R; Moreno-Coutiño G; Vásquez E; Fernández R; Chang P
Actas Dermosifiliogr; 2014; 105(1):5-17. PubMed ID: 23107866
[TBL] [Abstract][Full Text] [Related]
25. Cryptococcal meningoencephalitis diagnosed by blood culture.
Sivasangeetha K; Harish BN; Sujatha S; Parija SC; Dutta TK
Indian J Med Microbiol; 2007 Jul; 25(3):282-4. PubMed ID: 17901653
[TBL] [Abstract][Full Text] [Related]
26. [Mechanism of Cryptococcus Meningoencephalitis].
Miyazato A
Med Mycol J; 2016; 57(1):J27-32. PubMed ID: 26936349
[TBL] [Abstract][Full Text] [Related]
27. Characteristics and specificities of Cryptococcus infections in French Guiana, 1998-2008.
Debourgogne A; Iriart X; Blanchet D; Veron V; Boukhari R; Nacher M; Carme B; Aznar C
Med Mycol; 2011 Nov; 49(8):864-71. PubMed ID: 21612563
[TBL] [Abstract][Full Text] [Related]
28. A rare case of Cryptococcus gattii pneumonia in a renal transplant patient.
Cicora F; Petroni J; Formosa P; Roberti J
Transpl Infect Dis; 2015 Jun; 17(3):463-6. PubMed ID: 25689604
[TBL] [Abstract][Full Text] [Related]
29. Cryptococcus gattii genotype VGIIb infection in Japan.
Kawamura I; Kamei K; Yarita K; Ohkusu M; Ito K; Tsukahara M; Honda M; Nakashima K; Akamatsu H; Kurai H
Med Mycol J; 2014; 55(3):E51-4. PubMed ID: 25231224
[TBL] [Abstract][Full Text] [Related]
30. Cryptococcus neoformans and C. gattii isolates from both HIV-infected and uninfected patients: antifungal susceptibility and outcome of cryptococcal disease.
Nascimento E; Vitali LH; Kress MRVZ; Martinez R
Rev Inst Med Trop Sao Paulo; 2017; 59():e49. PubMed ID: 28793019
[TBL] [Abstract][Full Text] [Related]
31. Post-trauma primary cutaneous cryptococcosis in an immunocompetent host by Cryptococcus gattii VGII.
Pasa CR; Chang MR; Hans-Filho G
Mycoses; 2012 Mar; 55(2):e1-3. PubMed ID: 21736630
[No Abstract] [Full Text] [Related]
32. The epidemiology of cryptococcosis and the characterization of Cryptococcus neoformans isolated in a Brazilian University Hospital.
Aguiar PADF; Pedroso RDS; Borges AS; Moreira TA; Araújo LB; Röder DVDB
Rev Inst Med Trop Sao Paulo; 2017 Apr; 59():e13. PubMed ID: 28423088
[TBL] [Abstract][Full Text] [Related]
33. Differentiation of Cryptococcus neoformans varieties and Cryptococcus gattii using CAP59-based loop-mediated isothermal DNA amplification.
Lucas S; da Luz Martins M; Flores O; Meyer W; Spencer-Martins I; Inácio J
Clin Microbiol Infect; 2010 Jun; 16(6):711-4. PubMed ID: 19694768
[TBL] [Abstract][Full Text] [Related]
34. Clinical, epidemiological and outcome features of patients with cryptococcosis in Uberaba, Minas Gerais, Brazil.
Mora DJ; da Cunha Colombo ER; Ferreira-Paim K; Andrade-Silva LE; Nascentes GA; Silva-Vergara ML
Mycopathologia; 2012 Jun; 173(5-6):321-7. PubMed ID: 22130645
[TBL] [Abstract][Full Text] [Related]
35. The Cryptococcus neoformans genome sequencing project.
Heitman J; Casadevall A; Lodge JK; Perfect JR
Mycopathologia; 1999; 148(1):1-7. PubMed ID: 11086479
[TBL] [Abstract][Full Text] [Related]
36. Pharmacotherapy of cryptococcosis.
Ritter M; Goldman DL
Expert Opin Pharmacother; 2009 Oct; 10(15):2433-43. PubMed ID: 19708853
[TBL] [Abstract][Full Text] [Related]
37. What makes Cryptococcus gattii a pathogen?
Bielska E; May RC
FEMS Yeast Res; 2016 Feb; 16(1):fov106. PubMed ID: 26614308
[TBL] [Abstract][Full Text] [Related]
38. Management of Cryptococcus gattii meningoencephalitis.
Franco-Paredes C; Womack T; Bohlmeyer T; Sellers B; Hays A; Patel K; Lizarazo J; Lockhart SR; Siddiqui W; Marr KA
Lancet Infect Dis; 2015 Mar; 15(3):348-55. PubMed ID: 25467646
[TBL] [Abstract][Full Text] [Related]
39. Severe primary cutaneous Cryptococcus gattii causing ulcerative cellulitis in an immunocompetent patient.
Tan GSE; Singh R; Chong TYR; Su PQ; Lee JSS; Wong KJH; Tan JWL; Vasoo S
Lancet Infect Dis; 2019 Oct; 19(10):1148. PubMed ID: 31559968
[No Abstract] [Full Text] [Related]
40. Susceptibility profile of clinical and environmental isolates of Cryptococcus neoformans and Cryptococcus gattii in Uberaba, Minas Gerais, Brazil.
Andrade-Silva L; Ferreira-Paim K; Mora DJ; Da Silva PR; Andrade AA; Araujo NE; Pedrosa AL; Silva-Vergara ML
Med Mycol; 2013 Aug; 51(6):635-40. PubMed ID: 23343452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
